RUNX3 Reverses Cisplatin Resistance in Esophageal Squamous Cell Carcinoma via Suppression of the Protein Kinase B Pathway

Thoracic Cancer - Australia
doi 10.1111/1759-7714.12370
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Apoptotic Effect of Gambogic Acid in Esophageal Squamous Cell Carcinoma Cells via Suppression of the NF-κB Pathway

Oncology Letters
Cancer ResearchOncology
2016English

Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells

PLoS ONE
Multidisciplinary
2014English

Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma

Cells
2018English

HOXB7 Mediates Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through Involvement of DNA Damage Repair

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Inhibitor- B Kinase in Tumor Promotion and Suppression During Progression of Squamous Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2007English

The Hippo Pathway Transcriptional Co-Activator, YAP, Confers Resistance to Cisplatin in Human Oral Squamous Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2015English

VRK1 Promotes Cisplatin Resistance by Up-Regulating C-Myc via C-Jun Activation and Serves as a Therapeutic Target in Esophageal Squamous Cell Carcinoma

Oncotarget
Oncology
2017English

Vasohibin 1 Inhibits Adriamycin Resistance in Osteosarcoma Cells via the Protein Kinase B Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2018English

Esophageal Squamous Cell Papilloma, Suspected of Squamous Cell Carcinoma.

Internal Medicine
Internal MedicineMedicine
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy